Jon Napitupulu

Oncodesign Precision Medicine (OPM) has regained full rights to its Parkinson’s disease treatment program, OPM-201, after Servier Laboratories shifted...

MIRAILAB BIOSCIENCE Inc., a Tokyo-based company specializing in NMN supplements, has partnered with Global Ocean Distribution Pte Ltd to...

Ellipses Pharma has launched its first large-scale Phase 1/2 oncology clinical trial in the United Arab Emirates (UAE) for...

TIXiMED, a clinical-stage pharmaceutical company, has secured a $2.65 million loan from the Helmsley Charitable Trust to advance its...

Tolerance Bio, Inc., a biopharmaceutical company, has formed a Scientific Advisory Board and completed a $20.2 million seed financing...

Colorado’s life sciences ecosystem flourished in 2024, raising $2.15 billion, a 46% increase from 2023, marking the second time...

BiVACOR, a clinical-stage medical device company, has successfully completed the initial phase of its FDA Early Feasibility Study (EFS)...

Insitro, a machine learning-driven drug discovery company, achieved a milestone in its collaboration with Bristol Myers Squibb, receiving $25...

Holoclara, a biotechnology company, has launched its first-in-human Phase 1 clinical trial for HC002, an orally available small molecule...

Benchstrength, a New York City-based venture capital firm, has closed its first fund with investments from prominent institutions like...